DEBIRI Combined With Chemotherapy and Bevacizumab in the Treatment of Unresectable Colorectal Cancer Liver Metastases
Clinical trial NCT06177288 · UNKNOWN
Trial details
- NCT number
- NCT06177288
- Sponsor
- Fudan University
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-01
- Primary completion
- 2025-01-01
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.